Akpan, J, Gardner, R, Wagle, S (1974) Studies on the effects of insulin and acetylcholine on activation of glycogen synthase and on glycogenesis in hepatocytes isolated from normal fed rats. Biochemical and Biophysical Research Communications 61: 222–229.
Google Scholar | Crossref | Medline Allison, DB, Paultre, F, Maggio, C, et al. (1995) The use of areas under curves in diabetes research. Diabetes Care 18: 245–250.
Google Scholar | Crossref | Medline | ISI Aravagiri, M, Teper, Y, Marder, SR (1999) Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharmaceutics & Drug Disposition 20: 369–377.
Google Scholar | Crossref | Medline | ISI Arisawa, H, Fukui, K, Fujise, N, et al. (2002a) General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjogren’s syndrome. 2nd communication: Effects on somatic nervous system and on autonomic nervous system and smooth muscle. Arzneimittelforschung 52: 81–88.
Google Scholar | Medline Arisawa, H, Fukui, K, Imai, E, et al. (2002b) General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjogren’s syndrome. 4th communication: Effects on gastrointestinal, urinary and reproductive systems and other effects. Arzneimittelforschung 52: 225–232.
Google Scholar | Medline Arisawa, H, Imai, E, Fujise, N, et al. (2002c) General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjogren’s syndrome. 2nd communication: Effects on general behaviours and central nervous system. Arzneimittelforschung 52: 14–20.
Google Scholar | Medline Banni, S, Carta, G, Murru, E, et al. (2012) Vagus nerve stimulation reduces body weight and fat mass in rats. PLoS ONE 7: e44813.
Google Scholar | Crossref | Medline | ISI Bi, X, He, X, Xu, M, et al. (2015) Acetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signaling. Cell Cycle 14: 2461–2472.
Google Scholar | Crossref | Medline | ISI Blanchard, OL, Smoliga, JM (2015) Translating dosages from animal models to human clinical trials: Revisiting body surface area scaling. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 29: 1629–1634.
Google Scholar | Crossref | Medline Chen, J, Huang, X-F, Shao, R, et al. (2017) Molecular mechanisms of antipsychotic drug-induced diabetes. Frontiers in Neuroscience 11: 643.
Google Scholar | Crossref | Medline Chiu, C-C, Chen, C-H, Chen, B-Y, et al. (2010) The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34: 866–870.
Google Scholar | Crossref | Medline | ISI Cooper, GD, Pickavance, LC, Wilding, JP, et al. (2005) A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology 181: 80–89.
Google Scholar | Crossref | Medline | ISI Day, EA, Ford, RJ, Steinberg, GR (2017) AMPK as a therapeutic target for treating metabolic diseases. Trends in Endocrinology & Metabolism 28: 545–560.
Google Scholar | Crossref | Medline de Greef, R, Maloney, A, Olsson-Gisleskog, P, et al. (2011) Dopamine D2 occupancy as a biomarker for antipsychotics: Quantifying the relationship with efficacy and extrapyramidal symptoms. AAPS Journal 13: 121–130.
Google Scholar | Crossref | Medline | ISI Deng, C (2013) Effects of antipsychotic medications on appetite, weight, and insulin resistance. Endocrinology and Metabolism Clinics 42: 545–563.
Google Scholar | Crossref | Medline | ISI Eglen, RM (2005) Muscarinic receptor subtype pharmacology and physiology. Progress in Medicinal Chemistry 43: 105–136.
Google Scholar | Crossref | Medline Falk, S, Lund, C, Clemmensen, C (2019) Muscarinic receptors in energy homeostasis: Physiology and pharmacology. Basic & Clinical Pharmacology & Toxicology 126: 66–76.
Google Scholar | Crossref | Medline FDA (2001) Drug Approval Package > Evoxac (cevimeline HCl) NDA #20-989: Evoxac Pharmacological Review (Administration Tusfad Ed). Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-989_Evoxac.cfm
Google Scholar FDA (2005) Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Available at: https://www.fda.gov/media/72309/download
Google Scholar Ferno, J, Ersland, KM, Duus, IH, et al. (2015) Olanzapine depot exposure in male rats: Dose-dependent lipogenic effects without concomitant weight gain. European Neuropsychopharmacology 25: 923–932.
Google Scholar | Crossref | Medline Foretz, M, Ancellin, N, Andreelli, F, et al. (2005) Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54: 1331–1339.
Google Scholar | Crossref | Medline | ISI Fox, RI, Fox, CM (2019) Management of Sjögren’s syndrome. In: Wallace, DJ, Hahn, BH (eds) Dubois’ Lupus Erythematosus and Related Syndromes (9th edn). London: Elsevier, pp.745–758.
Google Scholar | Crossref Gautam, D, Han, SJ, Duttaroy, A, et al. (2007) Role of the M3 muscarinic acetylcholine receptor in β-cell function and glucose homeostasis. Diabetes, Obesity and Metabolism 9: 158–169.
Google Scholar | Crossref | Medline Han, M, Deng, C, Burne, TH, et al. (2008) Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression. Psychoneuroendocrinology 33: 569–580.
Google Scholar | Crossref | Medline | ISI Hu, M, Wang, F, Li, X, et al. (2012) Regulation of hepatic lipin-1 by ethanol: Role of AMP-activated protein kinase/sterol regulatory element-binding protein 1 signaling in mice. Hepatology 55: 437–446.
Google Scholar | Crossref | Medline Jadeja, RN, Chu, X, Wood, C, et al. (2019) M3 muscarinic receptor activation reduces hepatocyte lipid accumulation via CaMKKβ/AMPK pathway. Biochemical Pharmacology 169: 113613.
Google Scholar | Crossref | Medline Johnson, DE, Yamazaki, H, Ward, KM, et al. (2005) Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia. Diabetes 54: 1552–1558.
Google Scholar | Crossref | Medline | ISI Jones, JG (2016) Hepatic glucose and lipid metabolism. Diabetologia 59: 1098–1103.
Google Scholar | Crossref | Medline Kapur, S, VanderSpek, SC, Brownlee, BA, et al. (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: A suggested solution based on in Vivo occupancy. Journal of Pharmacology and Experimental Therapeutics 305: 625–631.
Google Scholar | Crossref | Medline | ISI Keks, N, Schwartz, D, Hope, J (2019) Stopping and switching antipsychotic drugs. Australian Prescriber 42: 152–157.
Google Scholar | Crossref | Medline Kim, CE, Kim, YJ, Hwang, MW, et al. (2021) Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model. Biomedicine & Pharmacotherapy 139: 111571.
Google Scholar | Crossref | Medline Kim, SF, Huang, AS, Snowman, AM, et al. (2007) Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proceedings of the National Academy of Sciences of the United States America 104: 3456–3459.
Google Scholar | Crossref | Medline | ISI Komossa, K, Rummel-Kluge, C, Hunger, H, et al. (2010) Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews 2010: CD006654.
Google Scholar Lee, WH, Kim, SG (2010) AMPK-dependent metabolic regulation by PPAR agonists. PPAR Research 2010: 549101.
Google Scholar | Crossref | Medline Li, JH, Gautam, D, Han, S-J, et al. (2009) Hepatic muscarinic acetylcholine receptors are not critically involved in maintaining glucose homeostasis in mice. Diabetes 58: 2776–2787.
Google Scholar | Crossref | Medline Li, X, Zhang, Y, Jin, Q, et al. (2018) Liver kinase B1/AMP-activated protein kinase-mediated regulation by gentiopicroside ameliorates P2X7 receptor-dependent alcoholic hepatosteatosis. British Journal of Pharmacology 175: 1451–1470.
Google Scholar | Crossref | Medline Li, Y, Zhao, X, Feng, X, et al. (2016) Berberine alleviates olanzapine-induced adipogenesis via the AMPKα-SREBP pathway in 3T3-L1 cells. International Journal of Molecular Sciences 17: 1865.
Google Scholar | Crossref Lian, J, Deng, C (2020) The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats. Pharmacology Biochemistry and Behavior 191: 172878.
Google Scholar | Crossref | Medline Lian, J, Huang, X-F, Pai, N, et al. (2014a) Preventing olanzapine-induced weight gain using betahistine: A study in a rat model with chronic olanzapine treatment. PLoS ONE 9: e104160.
Google Scholar | Crossref | Medline Lian, J, Huang, XF, Pai, N, et al. (2014b) Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways. Psychoneuroendocrinology 48: 77–86.
Google Scholar | Crossref | Medline | ISI Lian, J, Huang, X-F, Pai, N, et al. (2016) Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications. Pharmacological Research 106: 51–63.
Google Scholar | Crossref | Medline Liu, X, Deng, C, Cao, S, et al. (2015a) Acute effects of oral olanzapine treatment on the expression of fatty acid and cholesterol metabolism-related gene in rats. Life Sciences 128: 72–78.
Google Scholar | Crossref | Medline Liu, X, Lian, J, Hu, C-H, et al. (2015b) Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways. Pharmacological Research 100: 36–46.
Google Scholar | Crossref | Medline Liu, X, Wu, Z, Lian, J, et al. (2017) Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats. Scientific Reports 7: 2762.
Google Scholar Liu, X-M, Zhao, X-M, Deng, C, et al. (2019) Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway. Acta Pharmacologica Sinica 40: 1049–1057.
Google Scholar | Crossref | Medline Mamakou, V, Thanopoulou, A, Gonidakis, F, et al. (2018) Schizophrenia and type 2 diabetes mellitus. Psychiatriki 29: 64–73.
Google Scholar | Crossref | Medline Matsuhisa, M, Yamasaki, Y, Shiba, Y, et al. (2000) Important role of the hepatic vagus nerve in glucose uptake and production by the liver. Metabolism 49: 11–16.
Google Scholar | Crossref | Medline Matthews, DR, Hosker, JP, Rudenski, AS, et al. (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419.
Google Scholar | Crossref | Medline | ISI Merlin, J, Evans, BA, Csikasz, RI, et al. (2010) The M3-muscarinic acetylcholine receptor stimulates glucose uptake in L6 skeletal muscle cells by a CaMKK–AMPK-dependent mechanism. Cellular Signalling 22: 1